<DOC>
	<DOC>NCT01630278</DOC>
	<brief_summary>Very premature infants with a large ductus, selected by an early echocardiogram, will receive either ibuprofen or placebo before 12 hours of life. Follow-up will include repeated echocardiograms and cranial ultrasound at 36 hours, 14 days and 36 weeks of postconceptional age. The primary outcome will be survival without cerebral palsy at years.</brief_summary>
	<brief_title>Early Ibuprofen Treatment of Patent Ductus Arteriosus (PDA) in Premature Infants (TRIOCAPI)</brief_title>
	<detailed_description />
	<mesh_term>Ductus Arteriosus, Patent</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Gestational less than 28 weeks Postnatal age less than 12 hours</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>28 Weeks</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Prematurity</keyword>
	<keyword>patent ductus arteriosus</keyword>
	<keyword>ibuprofen</keyword>
</DOC>